Vearing, Christopher <br/><br/>
Concurrent binding of anti-EphA3 antibody and ephrin-A5 amplifies EphA3 signaling and downstream responses: potential as EphA3-specific tumor-targeting reagents.  [electronic resource] 

 -  Cancer research  Aug 2005 
 - 6745-54 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0008-5472 
<br/><br/><label>Standard No.: </label>10.1158/0008-5472.CAN-05-0758  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal--metabolism<br/>Cell Line, Tumor<br/>Ephrin-A5--metabolism<br/>Humans<br/>Immunoconjugates--pharmacokinetics<br/>Indium Radioisotopes--pharmacokinetics<br/>Melanoma--diagnostic imaging<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>Precursor B-Cell Lymphoblastic Leukemia-Lymphoma--diagnostic imaging<br/>Protein Structure, Tertiary<br/>Radionuclide Imaging<br/>Receptor Protein-Tyrosine Kinases--immunology<br/>Receptor, EphA3<br/>Receptors, Fc--metabolism<br/>Signal Transduction<br/>Substrate Specificity<br/>Tissue Distribution<br/>Transplantation, Heterologous